These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8115640)

  • 21. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
    Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?
    Szucs-Farkas Z; Toth J; Balazs E; Galuska L; Burman KD; Karanyi Z; Leovey A; Nagy EV
    AJR Am J Roentgenol; 2002 Oct; 179(4):1005-10. PubMed ID: 12239055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging in diagnosis and follow-up of minimal thyroid ophthalmopathy.
    Matsuo H; Motomura M; Takeo G; Yoshimura T; Tsujihata M; Nagataki S
    Jpn J Med; 1991; 30(3):229-32. PubMed ID: 1920963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI measurements of orbital tissues in dysthyroid ophthalmopathy.
    Nishida Y; Tian S; Isberg B; Tallstedt L; Lennerstrand G
    Graefes Arch Clin Exp Ophthalmol; 2001 Nov; 239(11):824-31. PubMed ID: 11789862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography.
    Yamamoto K; Itoh K; Yoshida S; Saito K; Sakamoto Y; Matsuda A; Saito T; Kuzuya T
    Endocrinol Jpn; 1979 Apr; 26(2):255-61. PubMed ID: 582582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.
    Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L
    Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of inflammation in idiopathic orbital myositis with fat-suppressed T2-weighted magnetic resonance imaging.
    Kubota T; Kano H
    Am J Ophthalmol; 2007 Apr; 143(4):718-20. PubMed ID: 17386294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L
    J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
    Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
    Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?
    Ott M; Breiter N; Albrecht CF; Pradier O; Hess CF; Schmidberger H
    Br J Radiol; 2002 Jun; 75(894):514-7. PubMed ID: 12124238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.
    Higashiyama T; Nishida Y; Ohji M
    Jpn J Ophthalmol; 2015 Nov; 59(6):430-5. PubMed ID: 26321629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Graves'ophthalmopathy: usefulness of T2 weighted muscle signal intensity].
    Sillaire I; Ravel A; Dalens H; Garcier JM; Boyer L
    J Radiol; 2003 Feb; 84(2 Pt 1):139-42. PubMed ID: 12717285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectus extraocular muscle paths and decompression surgery for Graves orbitopathy: mechanism of motility disturbances.
    Abràmoff MD; Kalmann R; de Graaf ME; Stilma JS; Mourits MP
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):300-7. PubMed ID: 11818370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy.
    Tachibana S; Murakami T; Noguchi H; Noguchi Y; Nakashima A; Ohyabu Y; Noguchi S
    Endocr J; 2010; 57(10):853-61. PubMed ID: 20733265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levator palpebrae superioris muscle: MR evaluation of enlargement as a cause of upper eyelid retraction in Graves disease.
    Ohnishi T; Noguchi S; Murakami N; Nakahara H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S; Watanabe K
    Radiology; 1993 Jul; 188(1):115-8. PubMed ID: 8511284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease].
    Maalouf T; Angioi-Duprez K; Beckendorff V; Malet T; George JL
    J Fr Ophtalmol; 1996; 19(12):748-54. PubMed ID: 9033899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy.
    Li Z; Luo Y; Feng X; Zhang Q; Zhong Q; Weng C; Chen Z; Shen J
    J Magn Reson Imaging; 2023 Oct; 58(4):1279-1289. PubMed ID: 36780178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.